» Articles » PMID: 20686680

G Protein-Coupled Receptor 87: a Promising Opportunity for Cancer Drug Discovery

Overview
Specialty Biochemistry
Date 2010 Aug 6
PMID 20686680
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

G protein-coupled receptors (GPRs) constitute one of the largest families of membrane proteins encoded by the human genome. Upon binding to various ligands, these seven-transmembrane receptors play an essential role in many physiological processes, including neurotransmission, immunity, inflammation, regulation of mood and behavior. In view of their important functions, aberrant expression and activity of GPRs have been implicated in a wide spectrum of diseases, including tumorigenesis. GPR87, a cell surface GPR related to the LPA receptor family, is overexpressed in diverse carcinomas and plays an essential role in tumor cell survival. In our recent work, we uncovered that GPR87 expression is regulated by the tumor suppressor p53 and by DNA damage in a p53-dependent manner. Moreover, we found that a lack of GPR87 triggers an increase in p53, concomitant with a decrease in Akt, which results in the sensitization of tumor cells to DNA damage-induced apoptosis and growth suppression. Altogether, we uncovered an essential function for GPR87 in p53-dependent cell survival in response to stress signals. Due to their unique structure, localization and ligand binding ability, GPRs have been extensively used for drug development and are the most common targets of commercial drugs. Although studies are required to determine GPR87 natural ligand(s) and signaling pathways, GPR87 is undoubtedly a very promising novel target for cancer prevention and treatment.

Citing Articles

The path of GPR87: from a P2Y-like receptor to its role in cancer progression.

Sak K Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39641798 DOI: 10.1007/s00210-024-03684-6.


GPR120 Gene expression and activity in subcutaneous and intramuscular adipose tissues of Angus crossbred steers.

Westbrook L, Johnson B, Gang G, Toyonaga K, Kang E, Smith S J Anim Sci. 2023; 101.

PMID: 37638631 PMC: 10601922. DOI: 10.1093/jas/skad284.


A novel classifier combining G protein-coupled receptors and the tumor microenvironment is associated with survival status in glioblastoma.

Guo C, Yu C, Gao W, Ren D, Zhang Y, Zheng P Front Pharmacol. 2023; 14:1093263.

PMID: 37560473 PMC: 10407249. DOI: 10.3389/fphar.2023.1093263.


The Genetic Landscape of Familial Pulmonary Fibrosis.

Liu Q, Zhou Y, Cogan J, Mitchell D, Sheng Q, Zhao S Am J Respir Crit Care Med. 2023; 207(10):1345-1357.

PMID: 36622818 PMC: 10595451. DOI: 10.1164/rccm.202204-0781OC.


Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy.

Mirzaei S, Gholami M, Ang H, Hashemi F, Zarrabi A, Zabolian A Cells. 2021; 10(12).

PMID: 34943856 PMC: 8699513. DOI: 10.3390/cells10123348.


References
1.
Wu Q, Ding W, Mirza A, Van Arsdale T, Wei I, Bishop W . Integrative genomics revealed RAI3 is a cell growth-promoting gene and a novel P53 transcriptional target. J Biol Chem. 2005; 280(13):12935-43. DOI: 10.1074/jbc.M409901200. View

2.
Wise A, Gearing K, Rees S . Target validation of G-protein coupled receptors. Drug Discov Today. 2002; 7(4):235-46. DOI: 10.1016/s1359-6446(01)02131-6. View

3.
Saifudeen Z, Diavolitsis V, Stefkova J, Dipp S, Fan H, El-Dahr S . Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression. J Biol Chem. 2005; 280(24):23094-102. DOI: 10.1074/jbc.M414575200. View

4.
Oh D, Kim K, Kwon H, Seong J . Cellular and molecular biology of orphan G protein-coupled receptors. Int Rev Cytol. 2006; 252:163-218. DOI: 10.1016/S0074-7696(06)52003-0. View

5.
Tabata K, Baba K, Shiraishi A, Ito M, Fujita N . The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor. Biochem Biophys Res Commun. 2007; 363(3):861-6. DOI: 10.1016/j.bbrc.2007.09.063. View